BBC vs. CNCR ETF Comparison

Comparison of Virtus LifeSci Biotech Clinical Trials ETF (BBC) to Loncar Cancer Immunotherapy ETF (CNCR)
BBC

Virtus LifeSci Biotech Clinical Trials ETF

BBC Description

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.

Grade (RS Rating)

Last Trade

$27.10

Average Daily Volume

4,086

Number of Holdings *

90

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.44

Average Daily Volume

44,751

Number of Holdings *

71

* may have additional holdings in another (foreign) market
Performance
Period BBC CNCR
30 Days -5.29% -5.22%
60 Days -13.57% -13.45%
90 Days 3.98% 6.12%
12 Months 17.51% 20.44%
33 Overlapping Holdings
Symbol Grade Weight in BBC Weight in CNCR Overlap
ACLX D 0.9% 1.07% 0.9%
ALLO F 1.05% 0.95% 0.95%
ARVN D 0.81% 1.02% 0.81%
BCYC B 1.28% 1.39% 1.28%
BMEA F 0.66% 0.9% 0.66%
CGEM A 1.66% 1.57% 1.57%
CRBU F 0.55% 1.01% 0.55%
DAWN A 0.99% 1.5% 0.99%
GERN A 1.34% 2.87% 1.34%
IDYA C 0.97% 1.25% 0.97%
IGMS D 1.0% 1.1% 1.0%
IMTX D 0.9% 1.19% 0.9%
INBX C 1.05% 1.38% 1.05%
IOVA C 1.3% 1.16% 1.16%
ITOS B 0.86% 1.38% 0.86%
KURA C 1.33% 1.2% 1.2%
KYMR C 1.19% 1.25% 1.19%
LYEL C 1.02% 1.46% 1.02%
MGNX C 1.48% 1.37% 1.37%
MRUS B 1.37% 1.32% 1.32%
NRIX D 1.34% 1.37% 1.34%
NUVL C 0.72% 1.12% 0.72%
PGEN C 0.94% 1.39% 0.94%
RAPT F 0.35% 1.32% 0.35%
RCUS D 0.74% 1.18% 0.74%
REPL F 0.7% 1.01% 0.7%
RLAY D 0.5% 1.09% 0.5%
RVMD A 1.17% 1.56% 1.17%
RXRX D 0.68% 1.03% 0.68%
SMMT B 1.19% 1.06% 1.06%
SNDX C 0.89% 1.29% 0.89%
XNCR B 0.73% 1.21% 0.73%
ZNTL F 0.71% 1.17% 0.71%
BBC Overweight 57 Positions Relative to CNCR
Symbol Grade Weight
ALPN A 2.89%
VKTX B 2.86%
RNA A 2.65%
VERA C 2.27%
DYN C 1.82%
SANA B 1.72%
CYTK D 1.52%
LQDA C 1.5%
KROS C 1.38%
FDMT C 1.26%
COGT D 1.19%
KRYS C 1.18%
MLYS C 1.17%
PTGX D 1.09%
CRNX A 1.07%
ALXO A 0.99%
ARDX C 0.93%
CMPS C 0.9%
CLDX C 0.88%
PHAT D 0.86%
PCVX C 0.85%
ANAB B 0.85%
ARCT D 0.84%
XENE C 0.84%
MORF F 0.82%
ORIC D 0.81%
AKRO F 0.8%
MDGL C 0.78%
DVAX D 0.73%
BLTE C 0.71%
RCKT F 0.71%
ETNB F 0.7%
ARWR D 0.7%
OLMA D 0.69%
VIR F 0.68%
BEAM F 0.67%
TGTX B 0.67%
SRRK C 0.67%
RGNX D 0.65%
PLRX D 0.63%
NVAX F 0.62%
VRDN D 0.62%
TERN F 0.61%
ABCL F 0.61%
DNLI D 0.59%
SAVA B 0.58%
IMVT D 0.57%
NTLA D 0.57%
ALEC D 0.56%
CABA D 0.55%
QURE F 0.5%
PRTA F 0.45%
EDIT F 0.43%
VERV F 0.41%
IRON F 0.39%
CVAC F 0.38%
ALLK F 0.28%
BBC Underweight 38 Positions Relative to CNCR
Symbol Grade Weight
ACRV B -2.63%
ELVN A -2.13%
JANX A -1.79%
NUVB A -1.7%
HCM A -1.54%
TSVT D -1.51%
BPMC A -1.48%
MRK A -1.48%
EXEL B -1.47%
YMAB B -1.43%
MOR C -1.41%
IMCR D -1.37%
IPHA C -1.36%
AURA D -1.34%
BNTX D -1.33%
REGN C -1.33%
GMAB D -1.32%
VOR F -1.32%
BMY F -1.31%
SDGR F -1.31%
DCPH A -1.29%
ACET F -1.28%
TYRA B -1.27%
ERAS D -1.27%
GLUE C -1.26%
SWTX C -1.23%
PRLD D -1.22%
FHTX C -1.21%
STRO D -1.21%
KPTI F -1.14%
DNA F -1.12%
AUTL F -1.04%
LEGN F -0.96%
RPTX F -0.89%
FATE D -0.83%
MRSN D -0.81%
GNLX F -0.78%
IMRX F -0.73%
Compare ETFs